Herbal remedies: Issues in licensing and economic evaluation

PharmacoEconomics

Volumn 16, Issue 4, 1999, Pages 321-328

  Ashcroft, Darren M ^a   Li Wan Po, Alain ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT; HYPERICUM EXTRACT; PRIMROSE OIL;

ARTICLE; ATOPIC DERMATITIS; BRAIN DYSFUNCTION; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ECONOMIC EVALUATION; GASTROINTESTINAL SYMPTOM; GINKGO BILOBA; HEADACHE; HUMAN; LIVER TOXICITY; MASTALGIA; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SKIN MANIFESTATION; TRADITIONAL MEDICINE;

COMPLEMENTARY THERAPIES; COST-BENEFIT ANALYSIS; DRUG APPROVAL; DRUG COSTS; GREAT BRITAIN; HUMANS; LICENSURE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 0032728275     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916040-00001     Document Type: Article

References (39)

1. Germany leads in branded phytomedicines (news report). OTC Bull 1996; 14: 15
2. Ernst E. Over-the-counter complementary remedies used for arthritis. Pharm J 1998; 260: 830-1
3. Grünwald J, Büttel K. The European phytotherapeutics market: figures, trends, analyses. Drugs Germany 1996; 39: 6-11
4. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309: 107-11
5. Phytopharm's eczema herbs [news report]. Pharm J 1996; 257: 630
6. Grubowski HG, Vernon JM. Returns to research and development on new drug introductions in the 1980s. J Health Econ 1994; 13: 383-406
7. Brooks A. Viagra is licensed in Europe but rationed in Britain [news report]. BMJ 1998; 317: 765
8. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care professionals. London: The Pharmaceutical Press, 1996
9. Smith I. Commissioning complementary medicine. BMJ 1995; 310: 1151-2
10. Kleijnen J, de Craen AJM. The importance of the placebo effect: a proposal for further research. In: Ernst E, editor. Complementary medicine: an objective appraisal. Oxford: Butterworth-Heinemann, 1996
11. Oh VMS. The placebo effect: can we use it better? BMJ 1994; 309: 69-70
12. De Smet PAGM. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997; 54 (6): 801-40
13. Somberg J, Greenfield B, Tepper D. Digitalis: historical development in clinical medicine. J Clin Pharmacol 1985; 25: 484-9
14. Sheehan MP, Rustin MHA, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992; 340: 13-7
15. Withering W. An account of the Foxglove and some of it's medical uses: practical remarks on dropsy and other diseases. Birmingham: M. Sweney, 1785
16. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992; 126: 179-84
17. Sheehan MP, Atherton DJ. One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994; 130: 488-93
18. Sheehan MP, Stevens H, Ostlere LS, et al. Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year. Clin Exp Dermatol 1995; 20: 136-40
19. Perharic L, Shaw D, Leon C, et al. Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Vet Hum Toxicol 1995; 37: 562-6
20. Kleijnen J. Evening primrose oil: currently used in many conditions with little justification. BMJ 1994; 309: 824-5
21. Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema: relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989; 121: 75-90
22. Berth-Jones J, Graham-Brown RAC. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993; 341: 1557-60
23. Budeiri D, Li Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996; 17: 60-8
24. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992; 340: 1136-9
25. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled. double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 1997; 278: 1327-32
26. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775-6
27. De Smet PAGM, Nolan WA. St John's wort as an antidepressant; longer term studies are needed before it can be recommended in major depression, BMJ 1996; 313: 241-2
28. Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-8
29. Guidelines on psychotropic drugs for the EC. Eur Neuropsychopharmacol 1994; 4: 61-77
30. Jick SS, Dean AD, Jick H, Antidepressants and suicide. BMJ 1995; 310: 215-8
31. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221-4
32. Ernst E, editor. Complementary medicine: an objective appraisal. Oxford: Butterworth-Heinemann, 1996
33. Ernst E, De Smet PAGM. Risks associated with complementary therapies. In: Dukes MNG, editor. Meyler's side effects of drugs. 13th ed. Amsterdam: Elsevier, 1996: 1427-54
34. D'Arey PF. Adverse reactions and interactions with herbal medicines, Part 2: drug interactions. Adverse Drug React Toxicol Rev 1993; 12: 147-62
35. Stricht BV, Parvais OE, Vanhaelen-FustrU RJ, et al. Remedies may contain cocktail of active drugs [letter]. BMJ 1994; 308: 1162
36. Markowitz SB, Nunez CM, Klitzman S, et al. Lead poisoning due to Hai Ge Fen. JAMA 1994; 271: 932-4
37. Keane FM, Taylor NF, Higgins EM. Chinese herbal creams: the active component [abstract]. Br J Dermatol 1998; 139 Suppl. 51: 21
38. European Scientific Cooperative for Phytotherapy (ESCOP), Proposals for European monographs. Vols. 1-3. Meppel: ESCOP, 1990-1992
39. Ernst E. Bitter pills of nature; safety issues in complementary medicine. Pain 1995; 60: 237-8